Solventum Analyst Price Targets - Benzinga

Solventum Corp

SOLVNYSE

Trade with Public

Trade with Public

$87.04

-0.99-1.12%

Dern. MÀJ: Oct 7, 4:54 AM

$86.63

-1.40-1.59%

Aperçu Actualités Prévisions de résultats ÉvénementsObjectifs de coursDonnées financières Sentiment Actionnariat Comparer Options Rapport sur les stocks

Solventum Analyst Price Targets

Wall Street analyst price targets and consensus rating for Solventum (SOLV).

Price Target Range — 10 Quarters

Analyst Consensus — 15 Analysts

9Buy

4Hold

2Sell

Consensus RatingOverweight# Analysts15Avg. Consensus PT$89Upside to Avg. PT+2.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 14, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$95
Aug 6, 2026	UBS	Kevin Caliendo	PT Raise	Buy	$95→$101
Aug 6, 2026	Piper Sandler	Jason Bednar	PT Raise	Overweight	$92→$105
Aug 6, 2026	Wedbush	Michael Piccolo	PT Raise	Outperform	$94→$101
Aug 6, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$93→$102
Aug 6, 2026	Stifel	Rick Wise	PT Raise	Buy	$90→$100
Aug 6, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$91→$95
Jul 28, 2026	UBS	Kevin Caliendo	Upgrade	Neutral→Buy	$95
Jul 9, 2026	BMO Capital	—	Initiate	Market Perform	$81
May 15, 2026	Wedbush	Michael Piccolo	Initiate	Outperform	$94
May 6, 2026	UBS	Kevin Caliendo	PT Cut	Neutral	$82→$78
May 6, 2026	Stifel	Rick Wise	PT Cut	Buy	$105→$90
May 6, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Equal-Weight	$83→$70
May 6, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$92→$93
May 6, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$89
Apr 27, 2026	Keybanc	Brett Fishbin	PT Cut	Overweight	$99→$92
Apr 17, 2026	Piper Sandler	Jason Bednar	PT Cut	Overweight	$98→$92
Mar 24, 2026	Rothschild & Co	Jackson Philips	Initiate	Sell	$60
Feb 27, 2026	Wells Fargo	Vik Chopra	PT Cut	Equal-Weight	$86→$83
Feb 27, 2026	Keybanc	Brett Fishbin	PT Raise	Overweight	$97→$99

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
BTIG Reiterates Buy on Solventum, Maintains $95 Price Target

BTIG analyst Ryan Zimmerman reiterates Solventum (NYSE:SOLV) with a Buy and maintains $95 price target.

Benzinga Newsdesk

PRO
UBS Maintains Buy on Solventum, Raises Price Target to $101

UBS analyst Kevin Caliendo maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $95 to $101.

Benzinga Newsdesk

PRO
Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105

Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $92 to $105.

Benzinga Newsdesk

PRO
Wedbush Maintains Outperform on Solventum, Raises Price Target to $101

Wedbush analyst Michael Piccolo maintains Solventum (NYSE:SOLV) with a Outperform and raises the price target from $94 to $101.

Benzinga Newsdesk

PRO
Keybanc Maintains Overweight on Solventum, Raises Price Target to $102

Keybanc analyst Brett Fishbin maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $93 to $102.

Benzinga Newsdesk

PRO
Stifel Maintains Buy on Solventum, Raises Price Target to $100

Stifel analyst Rick Wise maintains Solventum (NYSE:SOLV) with a Buy and raises the price target from $90 to $100.

Benzinga Newsdesk